Literature DB >> 30430930

Analysis of long non-coding RNA profiled following MC-LR-induced hepatotoxicity using high-throughput sequencing.

Cong Wen1, Shu Yang1, Shuilin Zheng1, Xiangling Feng1, Jihua Chen1, Fei Yang1,2,3.   

Abstract

The occurrence of microcystin-LR(MC-LR) variant a known hepatotoxin constitutes a global public health concern. However, the molecular mechanisms underlying MC-LR-induced hepatotoxicity remain to be determined. The aim of this study was to investigate whether long noncoding RNAs (lncRNA) were involved in MC-LR-mediated hepatotoxicity using human normal liver cell line HL7702 to profile lncRNAs after 24 hr treatment with MC-LR. With the use of high-throughput sequencing techniques, data showed that the expression levels of 37, 33, 34, 35 lncRNA were significantly altered following exposure to 1, 2.5, 5, or 10 μM MC-LR, respectively. In particular, the expression levels of LINC00847, MIR22HG and LNC_00027 were markedly increased in all treatment groups. It is of interest that LNC_00027 was identified as a novel lncRNA. Quantitative real-time PCR (qPCR) was employed to determine the differentially expressed lncRNA levels. Analysis using Gene Ontology (GO) enrichment identified the functions of target genes involved in systems development, metabolism, and protein binding. Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis demonstrated that MC-LR exposure upregulated some important signaling pathways including pathway in cancer, PI3K-AKT signaling and MAPK pathway. In summary, data indicate that the MC-LR-induced alterations in lncRNA may be associated with hepatotoxicity and that upregulation of LINC00847, MIR22HG and LNC_00027 may play important roles in the observed MC-mediated liver damage.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30430930     DOI: 10.1080/15287394.2018.1532717

Source DB:  PubMed          Journal:  J Toxicol Environ Health A        ISSN: 0098-4108


  8 in total

1.  Long intergenic non-protein coding RNA 847 promotes laryngeal squamous cell carcinoma progression through the microRNA-181a-5p/zinc finger E-box binding homeobox 2 axis.

Authors:  Wei Li; Xionghui Hu; Xiaolin Huang
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

Review 2.  A Review of Cardiovascular Toxicity of Microcystins.

Authors:  Linghui Cao; Isaac Yaw Massey; Hai Feng; Fei Yang
Journal:  Toxins (Basel)       Date:  2019-08-30       Impact factor: 4.546

3.  Prodigiosin Promotes Nrf2 Activation to Inhibit Oxidative Stress Induced by Microcystin-LR in HepG2 Cells.

Authors:  Jihua Chen; Yuji Li; Fuqiang Liu; De-Xing Hou; Jingjing Xu; Xinying Zhao; Fei Yang; Xiangling Feng
Journal:  Toxins (Basel)       Date:  2019-07-12       Impact factor: 4.546

4.  Effects of Microcystin-LR on the Microstructure and Inflammation-Related Factors of Jejunum in Mice.

Authors:  Linghui Cao; Feiyu Huang; Isaac Yaw Massey; Cong Wen; Shuilin Zheng; Shuaishuai Xu; Fei Yang
Journal:  Toxins (Basel)       Date:  2019-08-21       Impact factor: 4.546

5.  De Novo Profiling of Long Non-Coding RNAs Involved in MC-LR-Induced Liver Injury in Whitefish: Discovery and Perspectives.

Authors:  Maciej Florczyk; Paweł Brzuzan; Maciej Woźny
Journal:  Int J Mol Sci       Date:  2021-01-19       Impact factor: 5.923

6.  TNRC6C-AS1 Promotes Thyroid Cancer Progression by Upregulating LPAR5 via miR-513c-5p.

Authors:  Chuanming Tong; Chuan Wang; Yajie Wang; Xiongsheng Xiao
Journal:  Cancer Manag Res       Date:  2021-08-06       Impact factor: 3.989

Review 7.  Microcystin Toxicokinetics, Molecular Toxicology, and Pathophysiology in Preclinical Rodent Models and Humans.

Authors:  Tarana Arman; John D Clarke
Journal:  Toxins (Basel)       Date:  2021-07-29       Impact factor: 4.546

8.  Expression of LINC00847 in Peripheral Blood Mononuclear Cells of Children with Asthma and Its Prediction between Asthma Exacerbation and Remission.

Authors:  Jiaying Hu; Zhike Wang; Suzhen Han; Kai Chen
Journal:  Genet Res (Camb)       Date:  2022-03-20       Impact factor: 1.588

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.